Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonquex vs Neulasta in elderly patients with aggressive B-cell NHL (AVOID)
NCT02044276Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2014
- Primary completion
- Aug 2017
- Modality
- Cytokines & Interferons, Carrier/Scaffold Proteins
- Countries
- 3
01
Overview
A Phase 3 trial of lipegfilgrastim in neutropenia, sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2014; status: completed.
02
Drugs
lipegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT02044276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044276.